WVE (WAVE Life Sciences) Float Percentage Of Total Shares Outstanding: 80.62% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WVE WAVE Life Sciences Ltd WVE
59 GF Score
Price $6.13
GF Value $4.36
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is WAVE Life Sciences Float Percentage Of Total Shares Outstanding?

WAVE Life Sciences WVE -0.08% 59 Float Percentage Of Total Shares Outstanding is 80.62% as of Jul. 15, 2026. GuruFocus rates WVE with a GF Score™ of 59/100 and a GF Value™ of $4.36 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, WAVE Life Sciences's float shares is 155.11 Mil. WAVE Life Sciences's total shares outstanding is 192.40 Mil. WAVE Life Sciences's float percentage of total shares outstanding is 80.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, WAVE Life Sciences's Insider Ownership is 0.90%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, WAVE Life Sciences's Institutional Ownership is 91.57%.

WVE
59GF Score
WAVE Life Sciences Ltd WVE
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WAVE Life Sciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

WAVE Life Sciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=155.11/192.40
=80.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 80.62% mean?
WAVE Life Sciences (WVE) has a Float Percentage Of Total Shares Outstanding of 80.62% as of Jul. 15, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on WAVE Life Sciences and its competitors.
Is WAVE Life Sciences' Float Percentage Of Total Shares Outstanding too high?
WAVE Life Sciences' current Float Percentage Of Total Shares Outstanding is 80.62%. Overall, WAVE Life Sciences has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does WAVE Life Sciences' Float Percentage Of Total Shares Outstanding compare to CGEM and LXRX?
WAVE Life Sciences' Float Percentage Of Total Shares Outstanding of 80.62% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on WAVE Life Sciences and its competitors. WAVE Life Sciences's current Float Percentage Of Total Shares Outstanding is 80.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WAVE Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, WAVE Life Sciences (WVE) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.36, compared to a current price of $6.13 — trading 40.6% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 80.62%. WAVE Life Sciences' overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For WAVE Life Sciences (WVE), the current Float Percentage Of Total Shares Outstanding is 80.62% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WAVE Life Sciences (WVE) Overvalued in 2026?

Based on GuruFocus' analysis, WAVE Life Sciences stock appears to be overvalued. The current stock price of $6.13 is trading 40.6% above its estimated GF Value™ of $4.36. GuruFocus considers WAVE Life Sciences to be Significantly Overvalued.

Key valuation signals for WVE:

  • Float Percentage Of Total Shares Outstanding: 80.62%
  • GF Value™: $4.36 vs. price of $6.13 (40.6% above fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the WVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WAVE Life Sciences Business Description

Other Exchanges 1U5:Germany
Address 7 Straits View No. 12-00, Marina One East Tower, Singapore, SGP, 018936
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
59GF Score

Get the complete analysis for WVE

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.13
Price
$4.36
GF Value